Armbruster, 2002 - Google Patents
On-Site Workplace Drug TestingArmbruster, 2002
- Document ID
- 14028427191377015596
- Author
- Armbruster D
- Publication year
- Publication venue
- On-site drug testing
External Links
Snippet
Drug testing is an everyday fact of life for millions of American workers. Truck drivers, retail sales individuals, government workers, and professional athletes are subject to drug testing. Workplace drug testing is now a well-established practice in the US and around the world …
- 238000003255 drug test 0 title abstract description 39
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/558—Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/493—Physical analysis of biological material of liquid biological material urine
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/10—Office automation, e.g. computer aided management of electronic mail or groupware; Time management, e.g. calendars, reminders, meetings or time accounting
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Walsh et al. | An evaluation of rapid point-of-collection oral fluid drug-testing devices | |
| Visher | A comparison of urinalysis technologies for drug testing in criminal justice | |
| Smith et al. | Forensic toxicology: an introduction | |
| Wiencek et al. | Rapid assessment of drugs of abuse | |
| US6653139B1 (en) | On-site drug testing method | |
| George et al. | Use of on-site testing for drugs of abuse | |
| Brcak et al. | European guidelines for workplace drug testing in oral fluid | |
| Towt et al. | ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs | |
| Cooper et al. | Guidelines for European workplace drug testing in oral fluid | |
| Mason et al. | Response to the US FDA LeadCare Testing Systems recall and CDC health alert | |
| Kranzler et al. | Evaluation of a point-of-care testing product for drugs of abuse; testing site is a key variable | |
| Beirness et al. | Evaluation of the drug evaluation and classification program: a critical review of the evidence | |
| Crown et al. | A critical review of the assumptions underlying drug testing | |
| Armbruster | On-Site Workplace Drug Testing | |
| Christophersen et al. | Drug analysis for control purposes in forensic toxicology, workplace testing, sports medicine and related areas | |
| Dalen et al. | Workplace drug testing (WDT) likely to increase in Europe: report from the First European Symposium on WDT including selected abstracts | |
| Sunshine | Preliminary tests for drugs of abuse. | |
| Irving | Drug testing in the military--technical and legal problems. | |
| Mason | Some realities and results of proficiency testing of laboratories performing toxicological analyses | |
| Kim | A lean six sigma evaluation and cost analysis of Alabama’s oral fluid roadside screening and confirmation testing program | |
| SCHWARTZ et al. | Evaluation of the EZ-SCREEN enzyme immunoassay test for detection of cocaine and marijuana metabolites in urine specimens | |
| Henry et al. | Pretrial drug testing: An overview of issues and practices | |
| Schwartz et al. | Laboratory tests for rapid screening of drugs of abuse in the workplace: a review | |
| Kim et al. | Evaluation of an automated reader and color interpretation-based immunoassays for multiplexed drug-of-abuse testing in urine | |
| Crouch | Point of Collection Drug Testing |